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C = capacitance; ε = permittivity; EIS = electrical impedance scanning; R = resistance; σ = conductance; SMM = 99mTc-sestamibi scintimammo-
graphy; Z = magnitude.
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Introduction
Electrical impedance scanning (EIS) maps are a measure
of the electrical properties of an object made through
surface measurements. The information is obtained
quickly and comfortably, and the method shows promise
for detecting cancers that may have previously gone
undetected. The technology of electrical impedance mea-
surements in the detection of disease has become a
topic of great interest for engineering and physiological
scientists. As evidence of this, recent issues of IEEE
Transactions on Medical Imaging (June 2002) and of
Physiological Measurement (February 2001) have been
dedicated solely to these topics. Can the technology be
brought out of the laboratory? The following sections
present information about why EIS may be useful in breast
cancer detection and the clinical results to date.
Electrical properties of biological tissues
Electrical properties of living tissue
Interest and experimentation in the electrical properties of
tissues began in the late 1800s. This interest has evolved
into a branch of physiology and the research has lead to
insight into various mechanisms. This section provides an
overview of some electrical terminology that is used in
tissue impedance studies.
First are basic explanations of resistance (R), conductance
(σ), permittivity (ε) and capacitance (C). Resistance is a
property that opposes current flow, and conductance is the
inverse of resistance. Capacitance is a property that
opposes a change in voltage or electric potential across an
object and acts to store energy. A capacitor consists of two
conductors, each oppositely charged and separated by a
dielectric material. Permittivity is a property of the dielectric
material and reflects the ability of charges in the material to
move in response to an electric field. Capacitance is a func-
tion of the permittivity and the physical geometry of the
object. For example, the capacitance formula for a two-plate
capacitor is C = εA / d, where A is the area of each plate
and d is the distance between them. The complex imped-
ance (Z) of an RC series circuit can be described as Z =
R + jXc, where Xc = 1 / ωC (ω = 2πf, where f is frequency).
The representation of the impedance can also be in the
form of polar coordinates with Z = Z / θ, where Z is the mag-
nitude and θ is the phase angle of the impedance. Z is the
square root of R2 + Xc
2 and θ = arctan(Xc / R). Permittivity
and thus capacitance are usually considered to be constant
values, independent of frequency.
Since tissues consist of cells and extracellular medium,
their electrical properties determine those of tissues. The
Review
Technology review: The use of electrical impedance scanning in
the detection of breast cancer
Tyna A Hope1 and Siân E Iles2
1Department of Electrical and Computer Engineering, Dalhousie University, Halifax, Nova Scotia, Canada
2Department of Radiology, Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada
Corresponding author: Tyna A Hope (e-mail: tahope@dal.ca)
Published: 13 November 2003
Breast Cancer Res 2004, 6:69-74 (DOI 10.1186/bcr744)
© 2004 BioMed Central Ltd (Print ISSN 1465-5411; Online ISSN 1465-542X)
Abstract
The present paper focuses on electrical impedance scanning. The basic science behind the new
modality, measurements of breast tissue impedance in vivo and in vitro, and the studies performed
with a newly available commercial machine are discussed. Electrical impedance scanning has been
generating interest for several reasons, including comfort to the patient, the relatively low cost, and
studies suggest that it may be effective in detecting disease in mammographically dense breasts.
Keywords: dielectric properties, electrical impedance scanning70
Breast Cancer Research    Vol 6 No 2 Hope and Iles
extracellular medium consists primarily of ionic solutions.
The cell consists of the cellular membrane and the intra-
cellular medium. The cellular membrane consists of a lipid
bilayer and proteins. Due to this structure the cellular
membrane is primarily capacitive, with the exception of the
selective permeability that defines membrane conductivity.
Selective permeability is a function of the physiological
processes of the living cell. The intracellular material is an
ionic solution with microscopic structures and proteins
that can become charged and may move in response to
applied fields; they contribute to the cell’s electrical char-
acteristics.
Tissues exhibit frequency-dependent behavior beyond
simple RC circuits. In general terms this is because at dif-
ferent frequencies the different components (extracellular
medium, cell membrane and intracellular medium) con-
tribute to the impedance in varying amounts. Unlike in
manmade electrical systems, the conductance and permit-
tivity of tissues are not constant values, but are frequency
dependent and complex valued. Conductivity has been
found to be σ* = σ + jπεoε and permittivity to be ε* = ε +
jσ / πεo, where σ* is complex conductivity, σ is the real
portion of the conductivity, εo is the permittivity of free
space, ε is the relative permittivity of the material in ques-
tion, and ε* is the complex permittivity.
At low frequencies (<1000Hz) most of what is being mea-
sured is the ionic extracellular fluid properties, which are
primarily conductance values. At higher frequencies per-
mittivity, and thus capacitance, forms a larger portion of
the electrical impedance measured. From about 30 kHz to
30 MHz, the capacitive charging of the cell membrane and
the dipolar relaxation of proteins in the tissue determine
the permittivity. There exists a limited frequency range in
which the charging of the organelles within the cells con-
tributes significantly to the permittivity of the tissue. At fre-
quencies in the gigahertz range, the permittivity is primarily
due to bipolar relaxation of the water. When permittivity is
plotted as a function of frequency, it forms a piecewise
linear function. These ranges are known as alpha, beta,
delta and gamma, with relaxation frequencies defining the
boundaries of the ranges. Since the contribution to the
impedance is different due to different components at dif-
ferent frequencies, it may be more useful to obtain mea-
surements over several frequencies.
Electrical properties of nonliving tissue
Some of the electrical impedance experiments to be dis-
cussed have been performed in vitro. It has been proven
that there is a significant difference between the impedance
of normal living tissue and that of dead tissue. The imped-
ance changes as a function of time after death because the
permeability of the cell membrane changes within hours of
cell death. To reveal maximum information about living
tissue, impedance measurements must occur in vivo or
within minutes of death [1]. This fact can be a concern
when interpreting the results of in vitro experiments.
Measuring electrical impedance properties
For the purpose of defining the functional or pathological
properties of tissue, some researchers have been con-
cerned only with the resistance (inverse of conductance)
[2]. However, increasing interest has been generated in
identifying the complex impedance characteristics. The
primary interest in the past couple of decades has been
how the complex impedance might change as the func-
tional properties of the cell change. At present, cellular
impedance is frequently modeled by a combination of an
intracellular resistance, an extracellular resistance and a
transmembrane capacitance. This is a simplification since
the cell membrane also has a resistance, but it is consid-
ered negligible by most researchers.
Beyond investigating the impedance of tissues at select
frequencies, many researchers have looked at complex
impedance over ranges of frequencies. Some have
chosen to form Cole–Cole plots [3] to observe relation-
ships between pathology and the locus of Z versus fre-
quency. Cole performed experiments on a wide range of
cell types. Through his experiments he observed that the
variation of impedance with frequency approximates a
semicircle on the resistance–reactance plane. The center
of the semicircle is displaced positively on the resistance
axis, at a frequency known as the characteristic frequency
(fc). The semicircle has a radius of r = (R0 – R∞) / 2 where
Ro represents the DC frequency and R∞ represents the
value that the resistance approaches as the frequency
approaches infinity. While the semicircle locus works well
in theory, most collected data more closely represent a
semicircle with a depressed center. This fact caused Cole
to later modify the derived equations; however, not all
researchers included this modification in their application.
Cole found that when the impedance representing the
membrane (z3) was modified such that the phase angle
was constant over all frequencies, the locus represented a
depressed circle and more closely approximated the
experimental data (see Fig. 1).
Electrical characteristics of breast cancer
Breast cancer is presently detected by palpation (clinical
and self), by mammography, and by adjunct imaging
methods such as ultrasound and magnetic resonance
imaging. When suspicious lesions are detected, biopsies
are performed to determine whether the lesion is malig-
nant. At present, some mammographically suspicious
lesions are determined to be benign by a subsequent
biopsy (false-positive findings). The sensitivity of mam-
mography is decreased in women with mammographically
dense breasts. The search continues to locate the means
to diagnose breast cancer more accurately and less inva-
sively, and to provide earlier detection.71
From as early as 1926, researchers have been studying
the electrical properties of breast tumors [4]. While there
have been varying results, the consensus is that electrical
properties of breast tumors do differ from normal healthy
tissue. In 1988 Surowiec and colleagues [5] performed in
vitro tests to determine the variability of properties
between samples of breast carcinoma, samples with a
combination of carcinoma and healthy tissue including the
perceived boundary of the lesion, and samples of healthy
tissue only. This group concluded that the dielectric con-
stants and the conductivity of cancerous tissues differed
between the sample groups (as measured for frequencies
from 20 kHz to 100 MHz), although considerable variabil-
ity existed in the measured data.
Morimoto and colleagues [6,7] measured the electrical
impedance of breast tumors in vivo. This was accom-
plished via a three-electrode method by inserting a fine-
needle electrode into the tumor. They calculated the
extracellular resistance, the intracellular resistance, and
the membrane capacitance based on the measured
complex impedance and a model circuit. The model circuit
consisted of the extracellular resistance in parallel with a
series combination of the intracellular resistance and the
capacitance. The measurements were obtained over a fre-
quency range of 0–200 kHz. This group concluded that
there are statistically significant differences between
pathological and normal tissue. However, the range of
values calculated for each tissue type overlap. The authors
did not report in this work whether there is always a mea-
surable difference between the two sample types from a
single patient.
Jossinet [8–10] studied the impedance of six groups of
breast tissue over a frequency range of 488 Hz to 1 MHz.
The impedance spectra were obtained for 120 samples
obtained from 64 patients, with the sample groups divided
into three types of normal breast tissue, two types of
benign tissue, and carcinoma. All three articles present
studies using the same data. The first study by Jossinet
investigates the variability of the impedance data within
each group by assessing the standard deviation and the
reduced standard error [8].
In the second study by Jossinet, the complex impedance
was plotted versus frequency in a desire to compute the
Cole–Cole parameters. The study involved calculating
parameters to try to distinguish the carcinoma samples
from the rest of the samples [9]. Although many of the
impedance spectra do not approximate circular arcs, there
are obvious differences observed in the shape and loca-
tion of the various impedance loci on the reactance–resis-
tance plane. The second study suggests that there is a
greater difference in characteristics of cancerous tissues
at frequencies over 125 kHz.
Jossinet and Schmitt attempted, in the third study, to
define a new set of eight parameters by which cancerous
tissue can be differentiated from other tissues [10]. They
conclude that no one parameter at a single frequency is
sufficient to define the tissue but that several parameters
spanning a range of frequencies are appropriate.
Chauveau and colleagues [11] have also investigated the
need to calculate bio-impedance parameters over a variety
of frequency values. For ex vivo samples of normal and
pathological tissues, measurements were obtained for fre-
quencies that ranged from 10 KHz to 10 MHz. From these
measurements and a model that includes a constant
phase element, the extracellular resistance, the intracellu-
lar resistance, and the membrane capacitance were calcu-
lated from the measurements and a model that includes a
constant phase element. From these calculated values,
three indices are defined for classifying tissue pathology.
Based on the data presented it is suggested that these
parameters, and the indexes based on them, would allow
cancerous tissues to be differentiated from normal tissues
and those with fibrocystic changes.
All of the investigations reviewed have indicated a range of
absolute impedance values for a given tissue type. The vari-
ability among samples could be due to many causes. Some
suggestions have been population variance, experimental
errors, or compound tissue samples (cancer and healthy
tissue together). Another possibility is that cycling hor-
mones may affect the measured impedance of both healthy
and pathological tissues. Perlet and colleagues [12] inves-
tigated the stability of the measured impedance of healthy
breast tissue. Measurements were obtained once a week
over two consecutive menstrual cycles to determine
whether EIS images depend on hormones. It was deter-
mined that the images obtained varied throughout the
cycles with some consistency, and the authors concluded
that impedance is dependent on hormone levels.
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Figure 1
The locus of tissue impedance has a semicircle shape with an offset
center. R, resistance; Ro, DC frequency; R∞, value that the resistance









EIS produces an impedance map of an object based upon
the spatial electrical characteristics throughout the volume
of the object. When a current is injected into an object, by
Ohm’s law the voltage drop will be proportional to the
impedance of the object as long as the object has passive
electrical characteristics. In EIS, a known current is
injected into the surface and the voltage is measured at a
number of points (electrodes) on the surface of the object.
The resolution of the resultant image is dependent on the
number of electrodes. Areas of low impedance typically
appear on an EIS map as areas that have greater intensity
(whiter). A measure of the electrical properties of the
volume within the surface is obtained from these maps.
TransScan TS2000 and breast cancer
The following reviewed work is limited to research using
the Siemens TransScan TS2000 (Siemens Medical,
Germany, and TransScan, Ramsey, NJ, USA) as the EIS
methodology because it is the only commercially available
system for obtaining electrical impedance measurements
of the breast.
The information about the following TransScan TS2000
settings was obtained from the user manual document
# RD74010348 Rev. C. The TransScan TS2000 maps the
capacitance and conductance of the tissue, in two sepa-
rate images, in a range of frequencies that are selectable
for any of the available 26 frequencies. The images are
obtained via a square sensor array that is pressed against
the breast. The reference electrode is placed in the patien-
t’s hand. The images generated can either be high resolu-
tion (16 × 16) or low resolution (8 × 8). Each breast is
divided into nine sectors, with two images generated for
each sector indicating the conductance and capacitance
properties. The scans are preprocessed to produce a
smoothed image on the screen. Gray-scale mapping is
adjustable by the operator to allow enhancement of partic-
ular features. As with mammograms, the EIS images are
then assessed by a clinician who is trained to interpret the
results. The TransScan TS2000 is approved for use in the
United States and other countries as an adjunct modality.
There have been several studies on the use of the Trans-
Scan TS2000 to detect breast cancer lesions. A very early
study by Piperno and colleagues [13] was performed with
the prototype to the TransScan TS2000. ‘Mammoscan’
consisted of an 8 × 8 matrix of square electrodes, and four
images were obtained for each breast rather than nine
images. EIS was used to screen 6000 patients, of whom
745 underwent biopsy. All patients underwent an exami-
nation that included palpation, thermography, ultrasonic
examination, mammography, diaphanoscopy, and EIS. In
nine cases, EIS identified cancerous lesions where other
tests provided negative results. Furthermore, in five cases,
EIS clarified ambiguous findings and identified malignan-
cies. The study by Piperno and colleagues does not
specifically address the issue of false-positive findings.
They do identify that there are large differences in the
dielectric properties of the breast that vary with the individ-
ual. They recognized that, with their work, they are identify-
ing inhomogeneities in the breast and are assessing the
relative electrical properties within the images.
Melloul and colleagues [14] performed a study to assess
the performance of 99mTc-sestamibi scintimammography
(SMM) and of the TransScan TS2000 as adjunct modali-
ties. Included in the study were 121 patients, all of whom
had breast lesions detected and biopsied. Eighteen of the
121 patients had breast carcinoma. This group concluded
that that the TransScan TS2000 did not improve the rate
of detection when added to SMM use. There were,
however, five cases falsely determined to be malignant by
SMM that were correctly identified as benign by the
TransScan TS2000, and the TransScan TS2000 found
one tumor not detected by SMM. The greatest advantage
that the TransScan TS2000 offered in this study was its
ability to detect small lesions. The smallest lesion detected
by the TransScan TS2000 was 3 mm in diameter. The
sensitivity of the TransScan TS2000 was found to be
72.2% and the specificity was 67%.
Malich and colleagues [15] also performed a study to
assess the capability of the TransScan TS2000 to detect
breast cancer, and concluded it to be a valuable adjunct in
the assessment of breast lesions. The methods used in
this study include palpation, mammography, and ultra-
sound. Fifty-eight suspicious lesions were biopsied and
EIS provided 10 false-positive results, with some of these
false positives considered to be precancerous findings
(atypical hyperplasia). Most other studies did not quantify
the type of false-positive result, so it is difficult to assess
whether the TransScan TS2000 could be used reliably as
a method for detection of possibly precancerous lesions.
Malich and colleagues [16] published a more extensive
study in 2001, comparing the capabilities of ultrasound,
magnetic resonance imaging, and EIS to differentiate mam-
mographically suspicious lesions. The EIS measurements
were obtained during a targeted examination using 100
and 200 Hz reading frequencies. Radiologists who had
knowledge of the mammography findings evaluated all of
the imaging modalities. The EIS findings for sensitivity were
not significantly improved over ultrasound at 81% as com-
pared with 77%; however, the authors suggest that EIS
supplements ultrasound findings. In the same year, a more
comprehensive study [17] including 240 histologically
proven breast lesions indicated that the addition of EIS to
mammography and ultrasound increased the sensitivity
from 86.4% to 95.1%, but the accuracy decreased from
82.3% to 75.7%. The study also suggested that EIS has a
poor detection rate for ductal carcinoma in situ at 57.1%.
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Assenheimer and colleagues [18] presented a theoretical
discussion on the relationship between currents detected
at the breast’s surface and the electrical field distribution
within the breast. They also discuss a theoretical critical
measurement frequency at which the obscuring effect of
skin impedance is minimized. While the authors do not
supply data to support their discussion, it could be a
direction for further studies of the inverse problem in EIS
imaging. It may also be a direction towards improving the
data obtained with EIS.
In 2002, Martin and colleagues [19] studied correlations
between the histopathology of the breast and the features
of the EIS examination. This group found no correlation
between the intensity of the EIS signal and the depth of
the lesion. They did find a correlation between disagree-
ment between imaging results and histology to hormonal
status and the presence of benign proliferating lesions.
In another 2002 study, Piperno and Lenington [20] investi-
gated the ability of EIS to reflect the level of estrogen
activity in postmenopausal women. The study concluded
that nipple conductivity values were consistently higher for
women who use hormone replacement therapy. Since
increased estrogen activity may be associated with
increased risk of breast cancer, they believe EIS may be
useful for identifying women at increased risk.
The viability of electrical impedance measurements to
assist the clinician in the diagnosis of breast cancer is
clearly still under intense investigation. Some recent clinical
studies, such as the work by Wersebe and colleagues [21]
and Kneeshaw and colleagues [22], again provide conflict-
ing results. Wersebe and colleagues concluded that EIS
does not improve diagnostic accuracy, while Kneeshaw
and colleagues found favorable results in the ability of EIS
to detect occult microcalcification in the breast.
Although the aforementioned comprises much of the work
published by journals on the use of the TransScan
TS2000 in detecting breast cancer, more clinical data has
been obtained. Piperno has incorporated EIS into the
breast screening system at Pistoria, Italy since 1995. Also,
according to US Food and Drug Administration docu-
ments from January 1999, systems were operating at 41
sites in Israel, the United States, France, Italy, Greece,
Russia, Germany, China and South Korea. The applicabil-
ity of EIS is clearly under widespread investigation as an
adjunct imaging modality.
Other electrical impedance measurement methods
There are several research groups investigating other
forms of EIS, some of which will be discussed. One group
is located at Dartmouth College, Hanover, NH, USA.
Paulson and colleagues are using their own prototype
machine to obtain spectroscopic images of the breast.
With this system, the patient lays prone on a table contain-
ing a concave-shaped portion complete with electrodes.
The images obtained are of the absolute electrical con-
ductivity and permittivity over the range of frequencies
from DC to 1 MHz. When reporting the work of this group,
Osterman and colleagues [23] have indicated that the
impedance values are particularly sensitive to changes in
tissue properties when they are measured at or near the
center frequency of the tissue’s dispersion. They believe
that since they are measuring changes in tissue composi-
tion, one frequency is not likely to produce optimal images
in all cases. Kerner and colleagues [24] recently outlined
results of a study on the repeatability of the EIS examina-
tion using this system.
There is also an electrical impedance tomography
research group located in the Institute of Radio Engineer-
ing and Electronics of the Russian Academy of Sciences.
They have a system that is very similar in appearance to
the TransScan TS2000. Using the surface measure-
ments, Cherepenin and colleagues create three-dimen-
sional tomography images through a reconstruction
algorithm [25].
Newell, Issacson and Mueller at the Renesselaer Polytech-
nical Institute, Troy, NY, USA, have been actively working
on an electrical impedance tomography system and mathe-
matical reconstruction algorithms. With publications dating
back to 1986, this group has a significant level of experi-
ence in the field. Rather than list all of their publications, the
interested reader is left to investigate online themselves
(http://www.rpi.edu/~newelj/eit.html).
Discussion and conclusion
Based on the information reviewed EIS shows promise as
an adjunct modality, but still more work is required.
Studies show that the specificity and the sensitivity in
detection are increased when more than one modality is
used. Several reasons why EIS continues to be investi-
gated include the following:
• EIS measures a property of tissue not otherwise mea-
sured. Studies published as far back as 1926 indicate
that the electrical properties of cancerous tissues differ
from those of healthy tissue.
• EIS equipment is easy to use, is noninvasive, and
obtains the data in a way that is comfortable to
patients.
• EIS equipment is inexpensive, a fraction of the cost of
ultrasound machines.
• EIS has been shown to detect cancerous lesions as
small as 3 mm in diameter.
• Electrical impedance maps may be obtained easily;
acquisition takes about 15 min.
While the use of EIS imaging has some positive aspects
to it, there are several areas that need further work:
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• The differences in electrical properties of various
breast pathologies are not well documented. More
data are required to better categorize the information
contained in EIS mappings.
• The frequency response of both normal and pathologi-
cal breast tissue needs to be better understood. Key
features to identify breast cancer may be located at
frequencies not typically used.
• While some groups like Glickman and colleagues [26]
are looking at post-processing the output maps to
automatically discriminate between benign and normal
tissue, post-processing of EIS breast information is still
limited. Some valuable clinical information may be
presently overlooked.
• While three-dimensional reconstruction algorithms are
a topic of great interest, with Cherepenin and col-
leagues [25] and Mueller and colleagues [27] publish-
ing some promising results, there have been limited
data to indicate their robustness, which is required for
clinical application of these algorithms.
The work performed to date suggests that electrical prop-
erties of breast tissue change with the evolution from
normal healthy tissue to malignant tissue. The existence of
this property may provide an additional means to detect
breast cancer. The ability of the clinician to use this prop-
erty has been investigated over the past two decades, with
interest increasing with the development of a commercial
machine. While this technology will probably never become
the gold standard that mammography is today, further clini-
cal study may lead to EIS being reclassified from an experi-
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